Author

Herbert Tilg

Microbiota in NASH: Friends or foes?
Microbiota in NASH: Friends or foes?

Herbert Tilg

Autoimmune hepatitis: Always look at the whole picture / Autoimmune hepatitis: Always look at the whole picture
Autoimmune hepatitis: Always look at the whole picture / Autoimmune hepatitis: Always look at the whole picture

Herbert Tilg  et al.

Webinar | GI and liver complications of checkpoint inhibitors
Webinar | GI and liver complications of checkpoint inhibitors

Herbert Tilg  et al.

Words of welcome
Words of welcome

Herbert Tilg  et al.

What's new in Gastroenterology?
What's new in Gastroenterology?

Herbert Tilg

UEG Week Virtual: Words of welcome
UEG Week Virtual: Words of welcome

Herbert Tilg  et al.

The UEG Week Premiere
The UEG Week Premiere

Herbert Tilg  et al.

UEG Week+ | Basics to understand precision medicine: Fungi in GI
UEG Week+ | Basics to understand precision medicine: Fungi in GI

Herbert Tilg  et al.

European consensus conference on faecal microbiota transplantation in clinical practice
European consensus conference on faecal microbiota transplantation in clinical practice

Herbert Tilg  et al.

Best of UEG Week - Liver
Best of UEG Week - Liver

Herbert Tilg  et al.

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

Herbert Tilg  et al.

ORAL ABX464 QD IS EFFICACIOUS AND SAFE DURING PHASE 2B INDUCTION AND MAINTENANCE TREATMENT OF ULCERATIVE COLITIS PATIENTS
ORAL ABX464 QD IS EFFICACIOUS AND SAFE DURING PHASE 2B INDUCTION AND MAINTENANCE TREATMENT OF ULCERATIVE COLITIS PATIENTS

Herbert Tilg  et al.

NAD IMMUNOMETABOLISM IN NK CELL BIOLOGY DURING INTESTINAL INFLAMMATION
NAD IMMUNOMETABOLISM IN NK CELL BIOLOGY DURING INTESTINAL INFLAMMATION

Herbert Tilg  et al.

AZATHIOPRINE AND ANTI-TNF THERAPIES AFFECT THE GUT MICROBIOME DIFFERENTLY IN IBD PATIENTS
AZATHIOPRINE AND ANTI-TNF THERAPIES AFFECT THE GUT MICROBIOME DIFFERENTLY IN IBD PATIENTS

Herbert Tilg  et al.

TRAINED IMMUNITY IN LIVER CIRRHOSIS: FROM MOLECULAR MECHANISMS TO PROGNOSIS IMPLICATIONS. A PRELIMINARY OBSERVATION
TRAINED IMMUNITY IN LIVER CIRRHOSIS: FROM MOLECULAR MECHANISMS TO PROGNOSIS IMPLICATIONS. A PRELIMINARY OBSERVATION

Herbert Tilg  et al.

MICROBIAL INTERVENTION WITH BACTEROIDES THETAIOTAOMICRON PREVENTS STEATOSIS IN ALCOHOL-RELATED LIVER DISEASE PRECLINICAL MODEL BY MODULATING INTESTINAL HOMEOSTASIS
MICROBIAL INTERVENTION WITH BACTEROIDES THETAIOTAOMICRON PREVENTS STEATOSIS IN ALCOHOL-RELATED LIVER DISEASE PRECLINICAL MODEL BY MODULATING INTESTINAL HOMEOSTASIS

Herbert Tilg  et al.

ER STRESS AS A RHEOSTAT OF LIPID-INDUCED METABOLIC ENTERITIS IN CROHN’S DISEASE
ER STRESS AS A RHEOSTAT OF LIPID-INDUCED METABOLIC ENTERITIS IN CROHN’S DISEASE

Herbert Tilg  et al.

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease

Herbert Tilg  et al.

LIPID PEROXIDATION FUELS INTESTINAL INFLAMMATION VIA A TLR2-JNK AXIS
LIPID PEROXIDATION FUELS INTESTINAL INFLAMMATION VIA A TLR2-JNK AXIS

Herbert Tilg  et al.

Item 1 - 19 / 19
1